BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1106278)

  • 1. Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months.
    Decker JL; Klippel JH; Plotz PH; Steinberg AD
    Ann Intern Med; 1975 Nov; 83(5):606-15. PubMed ID: 1106278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis.
    Ginzler E; Diamond H; Guttadauria M; Kaplan D
    Arthritis Rheum; 1976; 19(4):693-9. PubMed ID: 782464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
    Austin HA; Klippel JH; Balow JE; le Riche NG; Steinberg AD; Plotz PH; Decker JL
    N Engl J Med; 1986 Mar; 314(10):614-9. PubMed ID: 3511372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis.
    Dinant HJ; Decker JL; Klippel JH; Balow JE; Plotz PH; Steinberg AD
    Ann Intern Med; 1982 Jun; 96(6 Pt 1):728-36. PubMed ID: 7046543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis.
    Steinberg AD; Decker JL
    Arthritis Rheum; 1974; 17(6):923-37. PubMed ID: 4611431
    [No Abstract]   [Full Text] [Related]  

  • 7. Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.
    Barnett EV; Dornfeld L; Lee DB; Liebling MR
    J Rheumatol; 1978; 5(3):275-87. PubMed ID: 372523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up.
    Carette S; Klippel JH; Decker JL; Austin HA; Plotz PH; Steinberg AD; Balow JE
    Ann Intern Med; 1983 Jul; 99(1):1-8. PubMed ID: 6344715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive agents in lupus nephritis: a critical analysis.
    Wagner L
    Medicine (Baltimore); 1976 May; 55(3):239-50. PubMed ID: 775253
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis.
    Felson DT; Anderson J
    N Engl J Med; 1984 Dec; 311(24):1528-33. PubMed ID: 6390198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus nephritis: clinical course in relation to treatment.
    Nanra RS; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1193-210. PubMed ID: 4803309
    [No Abstract]   [Full Text] [Related]  

  • 12. Azathioprine in steroid-insensitive nephropathy.
    Bardana EJ; Porter GA; Pirofsky B; Gourley RT; Bayrakci C
    Am J Med; 1970 Dec; 49(6):789-800. PubMed ID: 5006617
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis.
    Sabbour MS; Osman LM
    Br J Dermatol; 1979 Feb; 100(2):113-25. PubMed ID: 85455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression from minimal or focal to diffuse proliferative lupus nephritis.
    Zimmerman SW; Jenkins PG; Shelf WD; Bloodworth JM; Burkholder PM
    Lab Invest; 1975 May; 32(5):665-72. PubMed ID: 1092911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopathology in systemic lupus erythematosus. II. Relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4.
    Baker M; Hadler NM; Whitaker JN; Dunner DL; Gerwin RD; Decker JL
    Semin Arthritis Rheum; 1973; 3(2):111-26. PubMed ID: 4584527
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of azathioprine on lupus glomerulonephritis.
    Hayslett JP; Kashgarian M; Cook CD; Spargo BH
    Medicine (Baltimore); 1972 Sep; 51(5):393-412. PubMed ID: 4115512
    [No Abstract]   [Full Text] [Related]  

  • 18. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of primary chronic glomerulonephritis with a triple combination of prednisone, azathioprine and a nitrogen mustard derivative].
    Traver JA; Guajardo DS; Botella J
    Rev Clin Esp; 1975 May; 137(4):321-5. PubMed ID: 1144863
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].
    Purice S; Ghelerter L; Matei I; Brunazian G
    Stud Cercet Med Interna; 1969; 10(2):147-53. PubMed ID: 5344004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.